Voya Investment Management LLC Has $404.53 Million Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Voya Investment Management LLC decreased its holdings in Intuitive Surgical by 26.4% in the first quarter, reducing its ownership to 817,255 shares valued at approximately $404.53 million.
• Intuitive Surgical's recent quarterly earnings showed an EPS of $2.19, exceeding analysts' expectations with a revenue increase of 21.4% year-over-year to $2.44 billion.
• Analysts currently have a consensus rating of "Moderate Buy" for Intuitive Surgical, with a price target averaging $595.95 based on multiple rated recommendations from various financial institutions.

Voya Investment Management LLC reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 26.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 817,255 shares of the medical equipment provider's stock after selling 293,319 shares during the period. Voya Investment Management LLC owned about 0.23% of Intuitive Surgical worth $404,533,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. AlphaCore Capital LLC increased its position in Intuitive Surgical by 4.2% in the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock worth $235,000 after purchasing an additional 18 shares during the last quarter. Second Line Capital LLC boosted its stake in shares of Intuitive Surgical by 3.4% during the 4th quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock worth $302,000 after acquiring an additional 19 shares in the last quarter. Crown Wealth Group LLC boosted its stake in shares of Intuitive Surgical by 4.8% during the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock worth $218,000 after acquiring an additional 20 shares in the last quarter. FSM Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 3.8% during the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock worth $270,000 after acquiring an additional 20 shares in the last quarter. Finally, CFO4Life Group LLC boosted its stake in shares of Intuitive Surgical by 4.8% during the 1st quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider's stock worth $216,000 after acquiring an additional 20 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 1.3%

Shares of ISRG stock opened at $455.85 on Friday. The stock has a 50 day moving average of $487.55 and a two-hundred day moving average of $509.57. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The company has a market capitalization of $163.41 billion, a P/E ratio of 63.58, a P/E/G ratio of 4.72 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter last year, the company earned $1.78 EPS. The company's quarterly revenue was up 21.4% on a year-over-year basis. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ISRG has been the subject of several recent analyst reports. Royal Bank Of Canada reiterated an "outperform" rating and set a $615.00 price target on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Zacks Research downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th. Evercore ISI upped their price target on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 8th. Citigroup reiterated a "buy" rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Finally, Wells Fargo & Company increased their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research note on Wednesday, July 23rd. Thirteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $595.95.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the firm's stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the firm's stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company's stock, valued at $9,368,059.23. This represents a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.